Hydrocortisone topical: Difference between revisions
Elcatracho (talk | contribs) |
|||
| (11 intermediate revisions by 5 users not shown) | |||
| Line 5: | Line 5: | ||
==Adult Dosing== | ==Adult Dosing== | ||
===Dermatoses, steroid-responsive=== | |||
*Apply bid-QID | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===Dermatoses, steroid-responsive=== | |||
*Apply bid-QID | |||
==Special Populations== | ==Special Populations== | ||
| Line 19: | Line 21: | ||
*Allergy to class/drug | *Allergy to class/drug | ||
*caution if skin infection | *caution if skin infection | ||
*caution in pediatric | *caution in pediatric patients | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
| Line 26: | Line 28: | ||
*Cushing syndrome | *Cushing syndrome | ||
*hyperglycemia | *hyperglycemia | ||
*intracranial | *intracranial hypertension (pediatric patients) | ||
===Common=== | ===Common=== | ||
| Line 52: | Line 54: | ||
==See Also== | ==See Also== | ||
*[[Stress dose steroids]] | |||
*[[Hydrocortisone (systemic)]] | |||
== | ==References== | ||
<references/> | |||
[[Category:Pharmacology]] | |||
[[Category: | [[Category:Dermatology]] | ||
Latest revision as of 16:57, 24 May 2022
General
- Type: Topical steroid
- Dosage Forms: 0.5%, 1%, 2.5% crm, lotion, oint
- Common Trade Names: Cortizone, Cortaid, Hytone, Texacort
Adult Dosing
Dermatoses, steroid-responsive
- Apply bid-QID
Pediatric Dosing
Dermatoses, steroid-responsive
- Apply bid-QID
Special Populations
- Pregnancy Rating: C
- Lactation: Excretion in milk unknown; use with caution
- Renal Dosing: None
- Hepatic Dosing: None
Contraindications
- Allergy to class/drug
- caution if skin infection
- caution in pediatric patients
Adverse Reactions
Serious
- HPA axis suppresion
- Cushing syndrome
- hyperglycemia
- intracranial hypertension (pediatric patients)
Common
- burning
- pruritus
- irritation
- dryness
- folliculitis
- hypertrichosis
- acneiform dermatitis
- hypopigmentation
- perioral dermatitis
- allergic contact dermatitis
- maceration
- secondary infection
- skin atrophy
- striae
- miliaria
Pharmacology
- Half-life: 8-12h
- Metabolism: liver primarily; CYP450
- Excretion: urine
- Mechanism of Action: exact mechanim of anti-inflammatory action unknown; inhibits multiple inflammatory cytokines; produces multiple gluocorticoid and mineralocorticoid effects